Baylor University Medical Center Infectious Disease

Topics

• SARS-CoV-2 and COVID-19 Research 11
• HIV/AIDS drug development and treatment 10
• Respiratory viral infections research 8
• HIV Research and Treatment 6
• Hepatitis B Virus Studies 2
• Infection Control in Healthcare 2
• Influenza Virus Research Studies 2
• Tuberculosis Research and Epidemiology 2
• Antibiotic Resistance in Bacteria 1
• Antifungal resistance and susceptibility 1
• Antimicrobial Resistance in Staphylococcus 1
• Bacillus and Francisella bacterial research 1

Most cited

1. Capsid Inhibition with Lenacapavir in Multidrug-Resistant HIV-1 Infection.

   The New England journal of medicine · 2022 · 255 citations · Mezgebe Berhe

2. Interim Estimates of 2024-2025 COVID-19 Vaccine Effectiveness Among Adults Aged ≥18 Years - VISION and IVY Networks, September 2024-January 2025.

   MMWR. Morbidity and mortality weekly report · 2025 · 79 citations · Cristie Columbus

3. Safety and Efficacy of a Third Dose of BNT162b2 Covid-19 Vaccine.

   The New England journal of medicine · 2022 · 280 citations · Mezgebe Berhe

4. Severity of Respiratory Syncytial Virus vs COVID-19 and Influenza Among Hospitalized US Adults.

   JAMA network open · 2024 · 73 citations · Cristie Columbus

5. Lenacapavir administered every 26 weeks or daily in combination with oral daily antiretroviral therapy for initial treatment of HIV: a randomised, open-label, active-controlled, phase 2 trial.

   The lancet. HIV · 2023 · 98 citations · Mezgebe Berhe

6. Disease Severity of Respiratory Syncytial Virus Compared with COVID-19 and Influenza Among Hospitalized Adults Aged ≥60 Years - IVY Network, 20 U.S. States, February 2022-May 2023.

   MMWR. Morbidity and mortality weekly report · 2023 · 84 citations ·